There are no conflicts of interest related to this report.

All animal care and experimental procedures followed the guideline from the National Institutes of Health and the Institutional Animal Care and Use Committee (IACUC) at the University of Michigan. Use RNase-free solutions and pipette tips throughout the protocol. Clean the working area, pipettes, tubes, and centrifuge with RNase Decontamination solution following the manufacturer guidelines (see Materials Table).
1. sgRNA Target Selection
<ol>
	<li>Using a web browser, open ...

<ol>
	<li>Dickinson, D. J., Goldstein, B. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=CRISPR-Based+Methods+for+Caenorhabditis+elegans+Genome+Engineering.">CRISPR-Based Methods for Caenorhabditis elegans Genome Engineering.</a> Genetics. 202, 885-901 (2016).</li><li>Doudna, J. A., Charpentier, E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Genome+editing.+The+new+frontier+of+genome+engineering+with+CRISPR-Cas9.">Genome editing. The new frontier of genome engineering with CRISPR-Cas9.</a> Science. 346, 1258096 (2014).</li><li>Ma, D., Liu, F. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Genome+Editing+and+Its+Applications+in+Model+Organisms.">Genome Editing and Its Applications in Model Organisms.</a> Genomics Proteomics Bioinformatics. 13, 336-344 (2015).</li><li>Sander, J. D., Joung, J. K. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=CRISPR-Cas+systems+for+editing,+regulating+and+targeting+genomes.">CRISPR-Cas systems for editing, regulating and targeting genomes.</a> Nat Biotechnol. 32, 347-355 (2014).</li><li>Kim, H. M., Colaiacovo, M. P. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=CRISPR-Cas9-Guided+Genome+Engineering+in+C.+elegans.">CRISPR-Cas9-Guided Genome Engineering in C. elegans.</a> Curr Protoc Mol Biol. 115, 31-31 (2016).</li><li>Yin, H., Kauffman, K. J., Anderson, D. G. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Delivery+technologies+for+genome+editing.">Delivery technologies for genome editing.</a> Nat Rev Drug Discov. 16, 387-399 (2017).</li><li>Kim, S., Kim, D., Cho, S. W., Kim, J., Kim, J. S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Highly+efficient+RNA-guided+genome+editing+in+human+cells+via+delivery+of+purified+Cas9+ribonucleoproteins.">Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins.</a> Genome Res. 24, 1012-1019 (2014).</li><li>Haeussler, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Evaluation+of+off-target+and+on-target+scoring+algorithms+and+integration+into+the+guide+RNA+selection+tool+CRISPOR.">Evaluation of off-target and on-target scoring algorithms and integration into the guide RNA selection tool CRISPOR.</a> Genome Biol. 17, 148 (2016).</li><li>Paix, A., Folkmann, A., Seydoux, G. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Precision+genome+editing+using+CRISPR-Cas9+and+linear+repair+templates+in+C.+elegans.">Precision genome editing using CRISPR-Cas9 and linear repair templates in C. elegans.</a> Methods. , (2017).</li><li>Prior, H., Jawad, A. K., MacConnachie, L., Beg, A. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Highly+Efficient,+Rapid+and+Co-CRISPR-Independent+Genome+Editing+in+Caenorhabditis+elegans.">Highly Efficient, Rapid and Co-CRISPR-Independent Genome Editing in Caenorhabditis elegans.</a> G3 (Bethesda). 7, 3693-3698 (2017).</li><li>JoVE Science Education Database. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Basic+Methods+in+Cellular+and+Molecular+Biology.+PCR:+The+Polymerase+Chain+Reaction.">Basic Methods in Cellular and Molecular Biology. PCR: The Polymerase Chain Reaction.</a> J Vis Exp. , (2017).</li><li>Berkowitz, L. A., Knight, A. L., Caldwell, G. A., Caldwell, K. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Generation+of+stable+transgenic+C.+elegans+using+microinjection.">Generation of stable transgenic C. elegans using microinjection.</a> J Vis Exp. , (2008).</li><li>JoVE Science Education Database. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=+Basic+Methods+in+Cellular+and+Molecular+Biology.+Restriction+Enzyme+Digests."> Basic Methods in Cellular and Molecular Biology. Restriction Enzyme Digests.</a> J Vis Exp. , (2017).</li><li>JoVE Science Education Database. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Basic+Methods+in+Cellular+and+Molecular+Biology.+DNA+Gel+Electrophoresis+.">Basic Methods in Cellular and Molecular Biology. DNA Gel Electrophoresis .</a> J Vis Exp. , (2017).</li><li>JoVE Science Education Database. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Basic+Methods+in+Cellular+and+Molecular+Biology.+Gel+Purification.">Basic Methods in Cellular and Molecular Biology. Gel Purification.</a> J Vis Exp. , (2017).</li><li>Estrada-Rivadeneyra, D. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Sanger+sequencing.">Sanger sequencing.</a> FEBS J. , (2017).</li><li>Ludolph, A. C., Brettschneider, J., Weishaupt, J. H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Amyotrophic+lateral+sclerosis.">Amyotrophic lateral sclerosis.</a> Curr Opin Neurol. 25, 530-535 (2012).</li><li>Evans, T. C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=.">.</a> WormBook. , (2006).</li><li>Mello, C. C., Kramer, J. M., Stinchcomb, D., Ambros, V. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Efficient+gene+transfer+in+C.elegans:+extrachromosomal+maintenance+and+integration+of+transforming+sequences.">Efficient gene transfer in C.elegans: extrachromosomal maintenance and integration of transforming sequences.</a> EMBO J. 10, 3959-3970 (1991).</li><li>Jinek, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+programmable+dual-RNA-guided+DNA+endonuclease+in+adaptive+bacterial+immunity.">A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.</a> Science. 337, 816-821 (2012).</li><li>Boyd, S. D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+Balanced+Look+at+the+Implications+of+Genomic+(and+Other+&amp;#34;Omics&amp;#34;)+Testing+for+Disease+Diagnosis+and+Clinical+Care.">A Balanced Look at the Implications of Genomic (and Other &amp;#34;Omics&amp;#34;) Testing for Disease Diagnosis and Clinical Care.</a> Genes (Basel). 5, 748-766 (2014).</li><li>Saccon, R. A., Bunton-Stasyshyn, R. K., Fisher, E. M., Fratta, P. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Is+SOD1+loss+of+function+involved+in+amyotrophic+lateral+sclerosis?.">Is SOD1 loss of function involved in amyotrophic lateral sclerosis?.</a> Brain. 136, 2342-2358 (2013).</li><li>Acevedo-Arozena, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+comprehensive+assessment+of+the+SOD1G93A+low-copy+transgenic+mouse,+which+models+human+amyotrophic+lateral+sclerosis.">A comprehensive assessment of the SOD1G93A low-copy transgenic mouse, which models human amyotrophic lateral sclerosis.</a> Dis Model Mech. 4, 686-700 (2011).</li><li>Gurney, M. E., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Motor+neuron+degeneration+in+mice+that+express+a+human+Cu,Zn+superoxide+dismutase+mutation.">Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation.</a> Science. 264, 1772-1775 (1994).</li></ol>

We thank members of the Beg laboratory for critical reading of this manuscript. Strains were provided by the Caenorhabditis Genetics Center, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). Research in the Beg laboratory is supported by grants from the NIH (R01 NS094678) and Muscular Dystrophy Association (MDA382300) to A.A.B.

The CRISPR-Cas9 system is a powerful and effective tool for precisely modifying the genome of model organisms. Here, we demonstrate that chimeric sgRNAs20 coupled with ssODN HDR templates enable the highly efficient generation of genomic point mutations in C. elegans. Importantly, we demonstrate that RNP delivery produces high editing efficiency when fluorescence is used as a co-selection marker, highlighting the ease and reliability of the technique.
The major...

Recent technological advances have radically transformed and accelerated the ability to precisely engineer genomes. In particular, the CRISPR-Cas9 system, which relies on the RNA-guided endonuclease Cas9 to induce a double strand break (DSB) near the target sequence of interest, has been extensively used to accurately engineer the genome of the majority of model organisms used in biomedical research1,2,3,4. Significantly, the use of CRISPR-Cas9 has unlocked genome editing even in difficult species like C. elegans5. Regardless of species, generating point mutations with the CRISPR-Cas9 based genome editing system relies on three core components: 1) Cas9 endonuclease, 2) a single guide RNA (sgRNA) that directs the Cas9 endonuclease to a target sequence, and 3) a user designed homology-directed repair (HDR) template containing the desired edit(s) of interest2.
There are several methods that can be used to introduce the targeting sgRNA and Cas9 nuclease into cells including plasmid, RNA, and viral-based delivery methods6. Recently, direct delivery of pre-complexed sgRNA-Cas9 Ribonucleoproteins (RNPs) has emerged as a powerful and efficient tool in CRISPR-Cas9-based genome editing7. The direct delivery of pre-complexed CRISPR-Cas9 RNPs has several distinct advantages, namely: 1) RNPs bypass the need for cellular transcription and translation, 2) RNPs are rapidly cleared, which may increase specificity by reducing available time for off-target cleavage, and 3) RNPs contain no foreign DNA/RNA elements which circumvents the introduction of non-native sequences into the host genome through random integration. Together, these attributes likely provide a short-lived burst of on-target CRISPR editing while minimizing off-target effects.
We describe a simple and efficient protocol for introducing site-specific genomic changes in C. elegans. This protocol includes targeting sgRNA and single stranded oligonucleotide (ssODN) HDR template design, sgRNA-Cas9 RNP complexing and delivery, and a genotyping strategy for the unequivocal identification of properly edited animals. Using this strategy, not only can the desired site-specific changes be recovered, but other non-specific indel mutations may also be recovered. Thus, our strategy permits the generation of an allelic series using a single strategy, where both mono-allelic, bi-allelic, and indel mutants can be generated in the F1 generation.

<table border="0" cellpadding="0" cellspacing="0" width="1144">
	<tbody>
		<tr height="40">
			<td height="40" style="height:40px;width:359px;">CRISPRevolution sgRNA&#160; EZ Kit</td>
			<td style="width:216px;">Synthego Inc.</td>
			<td style="width:344px;"></td>
			<td style="width:227px;">chimeric sgRNA</td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;">Nuclease-free TE</td>
			<td>Synthego Inc.</td>
			<td>provided with the sgRNA kit EZ kit</td>
			<td></td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;">Nuclease-free water</td>
			<td>Synthego Inc.</td>
			<td>provided with the sgRNA kit EZ kit</td>
			<td></td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;">4 nmole Ultramer DNA Oligo</td>
			<td>Integrated DNA Technologies</td>
			<td></td>
			<td>ssODN HDR template</td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;">Alt-R S.p. HiFi Cas9 Nuclease 3NLS</td>
			<td>Integrated DNA Technologies</td>
			<td>1078728</td>
			<td>Cas9 protein</td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;">pCFJ90&#160;</td>
			<td>Addgene</td>
			<td>19327</td>
			<td>Pmyo-2::mCherry Marker Plasmid</td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;">KCl</td>
			<td>Sigma</td>
			<td>P5405</td>
			<td></td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;">HEPES</td>
			<td>Sigma</td>
			<td>H4034</td>
			<td></td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;">DNA Clean &#38; Concentrator</td>
			<td>Zymo Research</td>
			<td>D4004</td>
			<td></td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;">Zymoclean Gel DNA Recovery Kit</td>
			<td>Zymo Research</td>
			<td>D4002</td>
			<td></td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;">Q5 Hot Start High-Fidelity 2X Master Mix</td>
			<td>New England Biolabs</td>
			<td>M0494L</td>
			<td></td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;">Proteinase K</td>
			<td>Sigma</td>
			<td>P2308</td>
			<td></td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;">Glass Borosilicate Glass Micropipettes</td>
			<td>Sutter Instruments</td>
			<td>BF100-78-10</td>
			<td>OD: 1.0mm. ID: 0.78mm</td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;">Trizma Hydrochloride</td>
			<td>Sigma</td>
			<td>T5941</td>
			<td></td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;">MgCl2</td>
			<td>Sigma</td>
			<td>M2393</td>
			<td></td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;">NP-40</td>
			<td>Sigma</td>
			<td>74385</td>
			<td></td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;">Tween-20</td>
			<td>Fisher Scientific</td>
			<td>BP337-100</td>
			<td></td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;">RNaseZap Decontamination Solution</td>
			<td>Fisher Scientific</td>
			<td>AM9780</td>
			<td></td>
		</tr>
	</tbody>
</table>

a rapid and facile pipeline for generating genomic point mutants in c. elegans using crispr/cas9 ribonucleoproteins

The clustered regularly interspersed palindromic repeats (CRISPR)-CRISPR-associated protein 9 (Cas9) prokaryotic adaptive immune defense system has been co-opted as a powerful tool for precise eukaryotic genome engineering. Here, we present a rapid and simple method using chimeric single guide RNAs (sgRNA) and CRISPR-Cas9 Ribonucleoproteins (RNPs) for the efficient and precise generation of genomic point mutations in C. elegans. We describe a pipeline for sgRNA target selection, homology-directed repair (HDR) template design, CRISPR-Cas9-RNP complexing and delivery, and a genotyping strategy that enables the robust and rapid identification of correctly edited animals. Our approach not only permits the facile generation and identification of desired genomic point mutant animals, but also facilitates the detection of other complex indel alleles in approximately 4 - 5 days with high efficiency and a reduced screening workload.

Mutations in human superoxide dismutase 1 (SOD1) account for ~10 - 20% of familial amyotrophic lateral sclerosis, a devastating neurodegenerative disease that invariably leads to paralysis and death17. Human SOD-1 is an evolutionarily conserved protein sharing 55% identity and 70% similarity with the C. elegans SOD-1 protein (Figure 1B). To demonstrate the simplicity, feasibility, and efficiency of the CRISPR-Cas9 RNP...

Watch this Scientific Journal Video about A Rapid and Facile Pipeline for Generating Genomic Point Mutants in C. elegans Using CRISPR/Cas9 Ribonucleoproteins at JoVE.com

A Rapid and Facile Pipeline for Generating Genomic Point Mutants in C. elegans Using CRISPR/Cas9 Ribonucleoproteins

Here, we present a method to engineer the genome of C. elegans using CRISPR-Cas9 ribonucleoproteins and homology dependent repair templates.

A Rapid and Facile Pipeline for Generating Genomic Point Mutants in C. elegans Using CRISPR/Cas9 Ribonucleoproteins

The clustered regularly interspersed palindromic repeats (CRISPR)-CRISPR-associated protein 9 (Cas9) prokaryotic adaptive immune defense system has been ...

The overall goal of this procedure is to generate genomic point mutations in C.Elegans using single stranded oligonucleotide homology directed repair templates and CRISPR/Cas9 ribonucleoproteins. This method can help answer key questions in the neuroscience field such as determining the pathological consequences of genetic variance associated with neurodegenerative disease. The main advantage of this technique is that genomic point mutations can be generated rapidly allowing for the functional study of genetic variance within the context of endoginous regulatory control while avoiding the caveats of protein overexpression.To carry out sgRNA target selection, open up the webpage shown here. Input approximately 60 base pairs of sequence flanking the desired edit of interest. After selecting the C.Elegans genome and the protospacer adjacent motif according to the text protocol, click submit.On the results page, choose the top ranked target sequence closest to the edit of interest. Upon receipt, centrifuge the lyophilized sgRNA containing tube at room temperature and at least 12, 000 g for one minute. Add 60 microliters of nuclease free TE to the tube and use a p200 pipette to gently resuspend by pipetting up and down 15 to 20 times.The final concentration is 50 micromolar. Design an ssODN HDR template containing the mutation of interest, a unique in frame restriction endonuclease site, a silent mutation of one or both of the Gs within the NGG PAM sequence and 50 base pair five prime and three prime homology arms flanking the first and last mutation. Upon receipt, centrifuge the lyophilized ssODN containing tube as just demonstrated then use nuclease free DD H20 to gently resuspend ssODN to a final concentration of 100 micromolar.To prepare an injection mix, centrifuge the reagents shown here at maximum speed and four degrees celsius for two minutes. In the order listed, add the reagents to a nuclease free PCR tube. Then use a p20 pipette to gently and thoroughly mix the contents.Incubate the tube at room temperature for ten minutes. After injecting P0 animals according to the text protocol, allow them to recover at room temperature for one to two hours on an OP50 seeded 35 millimeter NGM plate. Subsequently using a platinum wire worm pick transfer single injected P0 animals to individual OP50 seeded 35 millimeter NGM plates.Two days post injection use a fluorescent microscope to identify P0 plates containing F1 progeny, expressing mCherry in the pharynx. Choose three P0 plates that contain the most mCherry positive F1 animals. From each of the three selected P0 plates use a worm pick to single eight to 12 mCherry positive F1 animals for a total of 24 to 36 mCherry positive F1s.Allow individual F1s to self fertilize and lay eggs at room temperature for one to two days. After one to two days of egg laying, use a worm pick to transfer the F1s into individual PCR strip tube caps containing seven microliters of worm lysis buffer. Centrifuge the PCR tubes at maximum speed and room temperature for one minute to bring the animals to the bottom of the tube.Then freeze the tubes at negative 80 degrees celsius for one hour. Next lyse frozen worms in a thermocycler using the following program. Then set up a PCR master mix as shown in this table.Add 21 microliters of PCR master mix into clean PCR tubes then add four microliters of the worm lysis tube and mix well by pipetting. Then run the PCR program following the manufacturer's guidelines. Purify the PCR reactions using a DNA clean and concentrate kit following the manufacturer's instructions.Then dilute the DNA by adding 10 microliters of water to the spin column. After setting up the restriction enzyme master mix add 10 microliters to each cleaned PCR reaction and incubate the tubes at 37 degrees celsius for one to two hours. Then separate the digested PCR products on a 1.5%agarose gel using 1x TAE buffer at 120 volts.Examine enzyme digested samples for the presence of bands that indicate potential edited animals. After identifying potential edited animals use the remaining three microliters of worm lysis and repeat the PCR. Then immediately load the completed reactions on a 1%agarose gel before separating and extracting the band using a gel extraction kit.Using the F1 primer carry out Sanger sequencing to identify correctly edited animals. Finally to obtain homozygous animals from verified heterozygous edited animals, single eight to 12 F2 animals and carry out genotyping and sequence verification according to the text protocol. To demonstrate the simplicity, feasibility, and efficiency of the CRISPR/Cas9 RNP based approach, the C.Elegans sod-1 gene was targeted to introduce the disease associated human G93a variant in the worm genome.This gel image shows the genotyping results for 24 mCherry positive F1 animals. 10 contained monoallylic or biallylic modification, 10 were wild type, three were potential indels, and one was a PCR failure. To demonstrate that the fluorescent mCherry marker enriches for genome modification, eight mCherry negative animals from each of the three P0 plates were picked.Only one animal was correctly modified whereas 23 were wild type. This figure shows the chromatogram from the full length gel extracted PCR product demonstrating that the precise nucleotide changes designed in the ssODN HDR template were faithfully incorporated into the genome of this homozygous F1 animal. Once mastered, this technique can be utilized to generate and identify genomic point mutations in C.Elegans in four to five days if it is performed properly.While attempting this procedure it's important to remember to use nucleus free reagents and techniques including RNase free water, filter pipette tips, and gloves. Following this procedure, cellular, molecular, and behavioral assays can be performed in order to investigate phenotypes that may associate with the mutation of interest. After watching this video you should have a good understanding of how to precisely generate genomic point mutations in C.Elegans using chimeric single guide RNase and CRISPR/Cas9 ribonuclearproteins.

a-rapid-facile-pipeline-for-generating-genomic-point-mutants-c

Research

JoVE Journal

Genetics

7.5K vistas.  University of Michigan. The overall goal of this procedure is to generate genomic point mutations in C.Elegans using single stranded oligonucleotide homology directed repair templates and CRISPR/Cas9 ribonucleoproteins. This method can help answer key questions in the neuroscience field such as determining the pathological consequences of genetic variance associated with neurodegenerative disease. The main advantage of this technique is that genomic point mutations can be generated rapidly allowing for the functiona...